Corticosteroid-induced myopathy in spinal cord injury patients: A role for anticatabolic agents? [1]

Spinal Cord

Volumn 44, Issue 4, 2006, Pages 263-264

  Dickerman, R D ^a   Joseph, A M ^a   Bennett, M T ^a  

^a North Texas Neurosurgical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; OXANDROLONE; PROGESTERONE;

CATABOLISM; CHRONOTHERAPY; COGNITION; CORTICOSTEROID INDUCED MYOPATHY; DRUG EFFECT; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG SUBSTITUTION; HUMAN; IMMUNE DEFICIENCY; LETTER; NEUROPROTECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE DRUG DOSE; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY;

ANABOLIC AGENTS; ANTI-INFLAMMATORY AGENTS; DRUG INTERACTIONS; HUMANS; METHYLPREDNISOLONE; MUSCLE, SKELETAL; MUSCULAR DISEASES; NEUROPROTECTIVE AGENTS; OXANDROLONE; PROGESTERONE; SPINAL CORD INJURIES;

EID: 33645728966     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sj.sc.3101814     Document Type: Letter

References (11)

1. Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 2005; 43: 199-203.
2. DeMaria EJ, Reichman W, Kenney PR, Armitage JM, Gann DS. Septic complications of corticosteroid administration after central nervous system trauma. Ann Surg 1985; 202: 248-252.
3. Russian DA, Levine SJ. Pneumocystitis carinii pneumonia in patients without HIV infection. Am J Med Sci 2001; 321: 56-65.
4. Molano Mdel R, Broton JG, Bean JA, Calancie B. Complications associated with the prophylactic use of methylprednisolone during surgical stabilization after spinal cord injury. J Neurosurg 2002; 96: 267-272.
5. Boumpas DT. Glucocorticoid therapy for immunemediated diseases: basic and clinical correlates. Ann Intern Med 1993; 119: 1198-1208.
6. Dickerman RD, Stevens QE, Schneider SJ. Sudden death secondary to fulminant intracranial aspergillosis in a healthy teenager after posterior fossa surgery: the role of corticosteroids and prophylactic recommendations. J Neurosurg Sci 2004; 48: 87-89.
7. Dickerman RD, Schneider SJ, Stevens QE, Matarese NM, Decker RE. Prophylaxis to avert exacerbation/relapse of multiple sclerosis in affected patients undergoing surgery. Surgical observations and recommendations. J Neurosurg Sci 2004; 48: 135-137.
8. Spungen AM, Koehler KM, Modeste-Duncan R, Rasul M, Cytryn AS, Bauman WA. 9 clinical cases of nonhealing pressure ulcers in patients with spinal cord injury treated with an anabolic agent: a therapeutic trial. Adv Skin Wound Care 2001; 14: 139-144.
9. Dickerman RD, Jaikumar S. The hiccup reflex arc and persistent hiccups with high-dose anabolic steroids: Is the brainstem the steroid-responsive locus? Clin Neuropharmacol 2001; 24: 62-64.
10. Djebaili M, Guo Q, Pettus EH, Hoffman SW, Stein DG. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma 2005; 22: 106-118.
11. Gonzalez SL, Labombarda F, Gonzalez Deniselle MC, Guennoun R, Schumacher M, De Nicola AF. Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord. Neuroscience 2004; 125: 605-614.